Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs Invesco Preferred ETF (PGX) Price & Performance

Intuitive Surgical, Inc.Trade
Invesco Preferred ETFTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs Invesco Preferred ETF — how do they compare? Intuitive Surgical, Inc. trades at $418 (market cap $146.76B), while Invesco Preferred ETF trades at $10.03 (market cap $3.60B). The key difference: Intuitive Surgical, Inc. is far larger — about 40.8× Invesco Preferred ETF's market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Invesco Preferred ETF for 94 Days on average.

ISRGPGX
Market Cap
$146.76B$3.60B
Volume
2,529,8145,986,026
Sector
Health—
52-Week High
$592.85$11.61
52-Week Low
$332.02$9.97
Typical Hold Time
84 Days94 Days
Enterprise Value
$141.54B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $414.52, up 2.41% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 2025 revenue reaching $10.06 billion and net income of $2.86 billion, maintaining impressive profit margins above 28%. Recent expansion into ambulatory surgery centers and international markets like India and Japan provides growth catalysts, though China headwinds present challenges. Technical indicators show bullish momentum with support at $411 and resistance at $417.

ISRG presents a compelling growth story with dominant market positioning in robotic surgery and strong recurring revenue streams. The stock offers 16% upside to the consensus price target of $480.78, supported by 70% analyst buy ratings. Key risks include competitive pressures in robotic surgery and international market volatility. The company's consistent earnings outperformance and expanding global footprint suggest continued growth potential despite near-term headwinds.

Invesco Preferred ETF

PGX trades at $9.97, down 0.89% today, with technical indicators showing a bearish trend from moving averages but oversold signals from the RSI. The stock faces pressure amid mixed sentiment, with key support and resistance levels clustered around $10. Recent corporate actions include scheduled dividends for July and September 2026, but fundamental data such as P/E and profitability metrics are unavailable for analysis.

The outlook for PGX is cautious due to the bearish technical setup and lack of current fundamental visibility. Risks include potential volatility near the $10 level and dependence on future financial disclosures to assess valuation. Investment opportunity hinges on upcoming earnings reports clarifying growth and margins, while sentiment remains divided amid limited recent news coverage.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ISRG
25% Buy75% Sell
Avg holding period · 84 Days
PGX
100% Buy0% Sell
Avg holding period · 94 Days

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →

About Invesco Preferred ETF

The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.

Read more on PGX →